发明名称 |
Varicella Zoster virus vaccine |
摘要 |
Use of an immunogenic composition comprising VZV gE, or immunogenic fragment thereof, and a TH-1 adjuvant in the preparation of a medicament for the prevention or amelioration of shingles and/or post herpetic neuralgia. Compositions comprising a truncated VZV gE antigen and an adjuvant containing QS21, cholesterol and 3D MPL arc also claimed. |
申请公布号 |
EP2281830(B1) |
申请公布日期 |
2016.12.21 |
申请号 |
EP20100188214 |
申请日期 |
2006.03.01 |
申请人 |
GlaxoSmithKline Biologicals SA |
发明人 |
Hanon, Emmanuel Jules;Stephenne, Jean |
分类号 |
C07K14/04;A61K39/00;A61K39/25;A61K39/39;A61P31/22 |
主分类号 |
C07K14/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|